The Role of Willingness of Participation in Cardiology Trials on the Survival of Patients

NCT03840499 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2019-02-15

No results posted yet for this study

Summary

It has been shown retrospectively that participation and even the willingness improves the survival of patients after myocardial infarction or heart failure. We aimed to prospectively analyse the role of participation in cardiology trials on the survival of patients in a high volumen tertiary center.

Conditions

Interventions

DRUG

Optimal medical therapy

Optimal medical therapy

Sponsors & Collaborators

  • Semmelweis University Heart and Vascular Center

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-01
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Hungary

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03840499 on ClinicalTrials.gov